<html>
<head>PUBMED IDs for IGLV3-2</head>
<body bgcolor='#C5F0F2'><h1>IGLV3-2</h1><a href='https://pubmed.ncbi.nlm.nih.gov/15466924/'>Geographic patterns and pathogenetic implications of IGHV gene usage in chronic lymphocytic leukemia: the lesson of the IGHV3-21 gene.</a> October 7  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/16076869/'>Immunoglobulin light chain repertoire in chronic lymphocytic leukemia.</a> August 4  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16985177/'>Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: Pathogenetic implications and clinical correlations.</a> September 21  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/18326815/'>Use of IGHV3-21 in chronic lymphocytic leukemia is associated with high-risk disease and reflects antigen-driven, post-germinal center leukemogenic selection.</a> March 11  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18948572/'>Evidence for the significant role of immunoglobulin light chains in antigen recognition and selection in chronic lymphocytic leukemia.</a> October 25  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19036101/'>Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study.</a> November 28  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19220298/'>Characterization of immunoglobulin heavy and light chain gene expression in chronic lymphocytic leukemia and related disorders.</a> June 20  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/25634617/'>Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations.</a> April 14  2015<br></body></html>
